NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: CLINICAL RESULTS OF A TBI-BASED CONDITIONING REGIMENBm Sandmaier, R Strob, DG Maloney et al.|Blood|2001Cited by 39
HLA-matched related (MRD) or unrelated donor (URD) nonmyeloablative conditioning and hematopoietic cell transplant (HCT) for patients with advanced Hodgkin disease (HD)Lauri M. Burroughs, David G. Maloney, Brenda M. Sandmaier et al.|Transplantation and Cellular Therapy|2004Cited by 16
Treatment for acute myelogenous leukemia by low dose Total Body Irradiation (TBI) based conditioning and hematopoietic cell transplantation from related and unrelated donorsGeorg‐Nikolaus Franke, Rainer Storb, Ute Hegenbart et al.|Transplantation and Cellular Therapy|2006Cited by 8
Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.Michael B. Maris, Rainer Storb, Brenda M. Sandmaier et al.|Blood|2004Cited by 7
Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)Mohamed L. Sorror, David G. Maloney, Michael B. Maris et al.|Transplantation and Cellular Therapy|2004Cited by 5